150 related articles for article (PubMed ID: 37656272)
1. Segmented in vitro fertilization and frozen embryo transfer in levonorgestrel-releasing intrauterine device treated patients with endometrial cancer.
Wei H; Pan N; Wang Y; Ma C
Arch Gynecol Obstet; 2023 Dec; 308(6):1845-1852. PubMed ID: 37656272
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year experience in one tertiary hospital in China.
Yin J; Li Y; Wang H; Wang W; Gu Y; Jin Y; Deng C; Pan L
Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():83-88. PubMed ID: 36436458
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
Giampaolino P; Di Spiezio Sardo A; Mollo A; Raffone A; Travaglino A; Boccellino A; Zizolfi B; Insabato L; Zullo F; De Placido G; Bifulco G
J Minim Invasive Gynecol; 2019; 26(4):648-656. PubMed ID: 30017893
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of in vitro fertilization cycles following fertility-sparing treatment in stage IA endometrial cancer.
Kim MJ; Choe SA; Kim MK; Yun BS; Seong SJ; Kim YS
Arch Gynecol Obstet; 2019 Oct; 300(4):975-980. PubMed ID: 31440822
[TBL] [Abstract][Full Text] [Related]
5. Analysis of risk factors for recurrence in infertile endometrial cancer patients after
Wei H; Pan N; Wang Y; Ma C
Front Endocrinol (Lausanne); 2023; 14():1224622. PubMed ID: 38075071
[TBL] [Abstract][Full Text] [Related]
6. Assessing ovarian stimulation with letrozole and levonorgestrel intrauterine system after combined fertility-sparing approach for atypical endometrial lesions: a retrospective case-control study.
Gallo A; Di Spiezio Sardo A; Conforti A; Iorio GG; Zizolfi B; Buonfantino C; De Angelis MC; Strina I; Marrone V; Bifulco G; Alviggi C
Reprod Biomed Online; 2024 May; 48(5):103750. PubMed ID: 38430660
[TBL] [Abstract][Full Text] [Related]
7. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
Novikova OV; Nosov VB; Panov VA; Novikova EG; Krasnopolskaya KV; Andreeva YY; Shevchuk AS
Gynecol Oncol; 2021 Apr; 161(1):152-159. PubMed ID: 33461741
[TBL] [Abstract][Full Text] [Related]
8. Analysis of IVF/ICSI outcomes in infertile women with early-stage endometrial cancer and atypical endometrial hyperplasia after conservative treatment.
Guo Y; Zong X; Li H; Qiao J
J Assist Reprod Genet; 2022 Jul; 39(7):1643-1651. PubMed ID: 35648323
[TBL] [Abstract][Full Text] [Related]
9. Association between outdoor air pollution during in vitro culture and the outcomes of frozen-thawed embryo transfer.
Wang X; Cai J; Liu L; Jiang X; Li P; Sha A; Ren J
Hum Reprod; 2019 Mar; 34(3):441-451. PubMed ID: 30689907
[TBL] [Abstract][Full Text] [Related]
10. Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
Lago V; Marina T; Laseca Modrego M; Gil-Ibañez B; Rodriguez JR; Domingo J; Minig L; Padilla-Iserte P; Arencibia Sánchez O; Sala Ferichola M; Munmanny M; Martín Salamanca B; Iacoponi S; Cabrera S; Coronado P; Utrilla-Layna J; Bataller Á; Fiol G; Corbalán S; Espinosa E; Gil-Moreno A; Domingo S;
Arch Gynecol Obstet; 2022 Sep; 306(3):821-828. PubMed ID: 35122158
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
Nucera G; Mandato VD; Gelli MC; Palomba S; La Sala GB
Gynecol Endocrinol; 2013 Mar; 29(3):219-21. PubMed ID: 23153053
[TBL] [Abstract][Full Text] [Related]
12. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
13. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
Bian J; Shao H; Liu H; Li H; Fang L; Xing C; Wang L; Tao M
Reprod Sci; 2015 Jun; 22(6):758-66. PubMed ID: 25536958
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol.
Zhao X; Niu J; Shi C; Liu Z
Reprod Health; 2022 Nov; 19(1):206. PubMed ID: 36333773
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Leone Roberti Maggiore U; Martinelli F; Dondi G; Bogani G; Chiappa V; Evangelista MT; Liberale V; Ditto A; Ferrero S; Raspagliesi F
J Gynecol Oncol; 2019 Jul; 30(4):e57. PubMed ID: 31074240
[TBL] [Abstract][Full Text] [Related]
17. Immediate versus delayed frozen embryo transfer in women following a failed IVF-ET attempt: a multicenter randomized controlled trial.
Song JY; Dong FY; Li L; Zhang XX; Wang AJ; Zhang Y; Gao DD; Xiao JM; Sun ZG
Reprod Biol Endocrinol; 2021 Aug; 19(1):131. PubMed ID: 34461950
[TBL] [Abstract][Full Text] [Related]
18. Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.
Li A; Zhang J; Kuang Y; Yu C
Front Endocrinol (Lausanne); 2020; 11():427. PubMed ID: 32765424
[No Abstract] [Full Text] [Related]
19. A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
Kim SW; Kim H; Ku SY; Suh CS; Kim SH; Choi YM
Gynecol Endocrinol; 2018 Jan; 34(1):15-19. PubMed ID: 28650773
[TBL] [Abstract][Full Text] [Related]
20. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
